Temat: "Lamivudine" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Development and validation of ultra performance liquid chromatography-tandem mass spectrometry method for the simultaneous estimation of dolutegravir, lamivudine and tenofovir in bulk and tablet dosage form.
Autorzy :: Veerareddy V; 208762Department of Pharmacy, 208762Anurag University (Formerly Anurag Group of Institutions), Hyderabad, India.
Dodda S; 208762Department of Pharmacy, 208762Anurag University (Formerly Anurag Group of Institutions), Hyderabad, India.
Gangarapu K; 208762Department of Pharmacy, 208762Anurag University (Formerly Anurag Group of Institutions), Hyderabad, India.; Pokaż więcej
Źródło :: European journal of mass spectrometry (Chichester, England) [Eur J Mass Spectrom (Chichester)] 2021 Dec; Vol. 27 (6), pp. 249-255. Date of Electronic Publication: 2021 Dec 01.
Typ publikacji :: Journal Article
MeSH Terms :: Lamivudine*
Tandem Mass Spectrometry*/methods
Chromatography, High Pressure Liquid/methods ; Chromatography, Liquid ; Heterocyclic Compounds, 3-Ring ; Oxazines ; Piperazines ; Pyridones ; Tablets ; Tenofovir
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR).
Autorzy :: Walimbwa SI; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. .
Kaboggoza JP; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Waitt C; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Byakika-Kibwika P; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.; Department of Medicine, Makerere University, Kampala, Uganda.
D'Avolio A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.; CoQua Lab, Turin, Italy.
Lamorde M; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.; Pokaż więcej
Źródło :: Trials [Trials] 2021 Nov 23; Vol. 22 (1), pp. 831. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Anti-HIV Agents*
Lamivudine*
Adenosine Monophosphate/analogs & derivatives ; Adult ; Alanine/analogs & derivatives ; Atazanavir Sulfate ; Healthy Volunteers ; Humans ; Oligopeptides ; Pyridines ; Ritonavir ; Tenofovir ; Uganda
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets.
Autorzy :: Godela R; GITAM Institute of Pharmacy, GITAM Deemed to be University, Visakhapatnam, India. Electronic address: .
Gummadi S; GITAM Institute of Pharmacy, GITAM Deemed to be University, Visakhapatnam, India.; Pokaż więcej
Źródło :: Annales pharmaceutiques francaises [Ann Pharm Fr] 2021 Nov; Vol. 79 (6), pp. 640-651. Date of Electronic Publication: 2021 May 19.
Typ publikacji :: Journal Article
MeSH Terms :: Lamivudine*
Chromatography, High Pressure Liquid ; Pyridones ; Tablets ; Tenofovir ; Triazoles
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Analysis of the ternary antiretroviral therapy dolutegravir, lamivudine and abacavir using UV spectrophotometry and chemometric tools.
Autorzy :: Serag A; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11751, Egypt. Electronic address: .
Hasan MA; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11751, Egypt.
Tolba EH; National Organization for Drug Control and Research (NODCAR), Giza, P.O. Box 35521, Egypt.
Abdelzaher AM; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11751, Egypt.
Elmaaty AA; Department of Medicinal Chemistry, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt. Electronic address: .; Pokaż więcej
Źródło :: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2022 Jan 05; Vol. 264, pp. 120334. Date of Electronic Publication: 2021 Aug 28.
Typ publikacji :: Journal Article
MeSH Terms :: HIV Infections*
Lamivudine*
Calibration ; Dideoxynucleosides ; Heterocyclic Compounds, 3-Ring ; Humans ; Least-Squares Analysis ; Oxazines ; Piperazines ; Pyridones ; Spectrophotometry ; Spectrophotometry, Ultraviolet
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Development and evaluation of the effect of ethanol and surfactant in vesicular carriers on Lamivudine permeation through the skin.
Autorzy :: Sudhakar K; Smriti College of Pharmaceutical Education, Indore, MP, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Mishra V; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India. Electronic address: .
Jain S; Department of Pharmacy, Medicaps University, Indore, MP, India.
Rompicherla NC; Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangaluru, (Karnataka), India.
Malviya N; Smriti College of Pharmaceutical Education, Indore, MP, India.
Tambuwala MM; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, United Kingdom. Electronic address: .; Pokaż więcej
Źródło :: International journal of pharmaceutics [Int J Pharm] 2021 Dec 15; Vol. 610, pp. 121226. Date of Electronic Publication: 2021 Oct 25.
Typ publikacji :: Journal Article
MeSH Terms :: Lamivudine*
Surface-Active Agents*
Administration, Cutaneous ; Drug Carriers ; Ethanol ; Liposomes ; Skin Absorption
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS).
Autorzy :: Lim ZC; Department of Pharmacy, Ng Teng Fong General Hospital, Singapore, Singapore.
Hoo GS; Department of Pharmacy, National Centre of Infectious Diseases, Singapore, Singapore. grace_sr_.; Department of Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore. grace_sr_.
Ang JH; Department of Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore.
Teng CB; Department of Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore.; Department of Pharmacy, National University of Singapore, Singapore, Singapore.
Ang LW; National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Singapore, Singapore.
Lee CC; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Leo YS; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Law HL; Department of Pharmacy, National Centre of Infectious Diseases, Singapore, Singapore.; Department of Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Ng OT; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Wong CS; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Pokaż więcej
Źródło :: AIDS research and therapy [AIDS Res Ther] 2021 Nov 01; Vol. 18 (1), pp. 80. Date of Electronic Publication: 2021 Nov 01.
Typ publikacji :: Journal Article
MeSH Terms :: Anti-HIV Agents*/adverse effects
HIV Infections*/drug therapy
HIV-1*/genetics
Lamivudine*/adverse effects
Dideoxynucleosides ; Humans ; Retrospective Studies ; Rilpivirine/adverse effects ; Singapore/epidemiology
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: Weight-adapted fixed-dose combined adult antiretroviral tablets for HIV-infected children.
Autorzy :: Bossacoma Busquets F; Fundació Sant Joan de Déu, Fundacio Salut Emporda, Pharmacy, Barcelona, Spain.
Sánchez E; Blanquerna Ramon Llull University Faculty of Health Sciences, Barcelona, Spain.
Noguera-Julián A; Hospital Sant Joan de Déu, Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Universitat de Barcelona, Pediatria, CIBER, Red de Investigación Translacional en Infectología Pediatrica, RITIP, Barcelona, Spain.
Villaronga Flaqué M; Hospital Sant Joan de Déu, Pharmacy, Barcelona, Spain.
Fortuny C; Hospital Sant Joan de Deu, Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Universitat de Barcelona, Pediatria, Red de Investigación Translacional en Infectología Pediátrica, RITIP, Barcelona, Spain.; Pokaż więcej
Źródło :: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Aug; Vol. 46 (4), pp. 867-871. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :: Journal Article
MeSH Terms :: Anti-HIV Agents/*therapeutic use
Dideoxynucleosides/*therapeutic use
HIV Infections/*drug therapy
Lamivudine/*therapeutic use
Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Body Height ; Body Weight ; CD4 Lymphocyte Count ; Child ; Child, Preschool ; Dideoxynucleosides/administration & dosage ; Dideoxynucleosides/adverse effects ; Dose-Response Relationship, Drug ; Drug Combinations ; Female ; Humans ; Lamivudine/administration & dosage ; Lamivudine/adverse effects ; Male ; Prospective Studies ; Spain ; Viral Load/drug effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.
Autorzy :: Hollinger A; Institute of Intensive Care, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. .; Medical Faculty, University of Basel, Basel, Switzerland. .
Cueni N; Institute of Intensive Care, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel, 4031, Basel, Switzerland.; Medical Faculty, University of Basel, Basel, Switzerland.
Dickenmann M; Department of Transplantation Immunology and Nephrology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.; Medical Faculty, University of Basel, Basel, Switzerland.
Landmann E; Department of Transplantation Immunology and Nephrology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Battegay M; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.; Medical Faculty, University of Basel, Basel, Switzerland.
Martinez AE; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Siegemund M; Institute of Intensive Care, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.; Medical Faculty, University of Basel, Basel, Switzerland.
Leuppi-Taegtmeyer A; Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.; Medical Faculty, University of Basel, Basel, Switzerland.; Pokaż więcej
Źródło :: AIDS research and therapy [AIDS Res Ther] 2021 Sep 04; Vol. 18 (1), pp. 56. Date of Electronic Publication: 2021 Sep 04.
Typ publikacji :: Case Reports; Journal Article; Review
MeSH Terms :: Acidosis, Lactic*/chemically induced
Anti-HIV Agents*/adverse effects
HIV Infections*/complications
HIV Infections*/drug therapy
Hyperlactatemia*/chemically induced
Kidney Transplantation*/adverse effects
Lamivudine*/adverse effects
Sepsis*/drug therapy
Aged ; Humans ; Male
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 9 9.

Tytuł :: Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants.
Autorzy :: Singh RP; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
Adkison K; Clinical Pharmacology, ViiV Healthcare, Research Triangle Park, North Carolina, USA.
Wolstenholme A; Clinical Pharmacology Science and Study Operations, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
Hopking J; Clinical Statistics, GlaxoSmithKline, Stockley Park, UK.
Wynne B; Clinical Development, ViiV Healthcare, Research Triangle Park, North Carolina, USA.; Pokaż więcej
Źródło :: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Sep; Vol. 10 (9), pp. 985-993. Date of Electronic Publication: 2021 Jul 15.
Typ publikacji :: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Anti-HIV Agents/*administration & dosage
Dideoxynucleosides/*administration & dosage
Heterocyclic Compounds, 3-Ring/*administration & dosage
Lamivudine/*administration & dosage
Oxazines/*administration & dosage
Piperazines/*administration & dosage
Pyridones/*administration & dosage
Administration, Oral ; Adult ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/pharmacokinetics ; Area Under Curve ; Asians ; Dideoxynucleosides/adverse effects ; Dideoxynucleosides/pharmacokinetics ; Drug Combinations ; Female ; Heterocyclic Compounds, 3-Ring/adverse effects ; Heterocyclic Compounds, 3-Ring/pharmacokinetics ; Humans ; Lamivudine/adverse effects ; Lamivudine/pharmacokinetics ; Male ; Middle Aged ; Oxazines/adverse effects ; Oxazines/pharmacokinetics ; Piperazines/adverse effects ; Piperazines/pharmacokinetics ; Pyridones/adverse effects ; Pyridones/pharmacokinetics ; Tablets ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: A simple alternative and improved HPLC method for the estimation of doravirine, lamivudine, and tenofovir disoproxil fumarate in solid oral dosage form.
Autorzy :: Kokkirala TK; Department of Chemistry, GITAM University, Visakhapatnam, Andhra Pradesh, India.
Kancherla P; Institute of Science and Technology, JNTU, Hyderabad, Telangana, India.
Alegete P; Department of Chemistry, JNTUH College of Engineering, Jagtial, Telangana, 505501, India.
Suryakala D; Department of Chemistry, GITAM University, Visakhapatnam, Andhra Pradesh, India.; Pokaż więcej
Źródło :: Biomedical chromatography : BMC [Biomed Chromatogr] 2021 Aug; Vol. 35 (8), pp. e5121. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji :: Journal Article
MeSH Terms :: Chromatography, High Pressure Liquid/*methods
Lamivudine/*analysis
Pyridones/*analysis
Tenofovir/*analysis
Triazoles/*analysis
Drug Stability ; Lamivudine/chemistry ; Limit of Detection ; Linear Models ; Pyridones/chemistry ; Reproducibility of Results ; Tablets ; Tenofovir/chemistry ; Triazoles/chemistry
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Lamivudine-conjugated and efavirenz-loaded G2 dendrimers: Novel anti-retroviral nano drug delivery systems.
Autorzy :: Pargoo EM; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Aghasadeghi MR; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Parivar K; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Nikbin M; Middle East Liver Diseases (MELD) Center, Tehran, Iran.
Rahimi P; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Ardestani MS; Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło :: IET nanobiotechnology [IET Nanobiotechnol] 2021 Sep; Vol. 15 (7), pp. 627-637. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :: Journal Article
MeSH Terms :: Dendrimers*
Lamivudine*/pharmacology
Alkynes ; Benzoxazines/pharmacology ; Cyclopropanes ; Drug Delivery Systems ; HEK293 Cells ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.
Autorzy :: Rojas J; Hospital d'Igualada, Barcelona, Spain.
de Lazzari E; Hospital Clínic-IDIBAPS, Barcelona, Spain.
Negredo E; Hospital Germans Trias i Pujol, Badalona, Spain; Lluita Contra La Sida Foundation, Badalona, Spain; Universitat de Vic-Universitat Central de Catalunya, Barcelona, Spain.
Domingo P; Hospital de Sant Pau, Barcelona, Spain.
Tiraboschi J; Hospital de Bellvitge, l'Hospitalet de Llobregat, Spain.
Ribera E; Hospital Vall d'Hebron, Barcelona, Spain.
Abdulghani N; Hospital Arnau de Vilanova, Lleida, Spain.
Puig J; Hospital Germans Trias i Pujol, Badalona, Spain; Lluita Contra La Sida Foundation, Badalona, Spain.
Mateo MG; Hospital de Sant Pau, Barcelona, Spain.
Podzamczer D; Hospital de Bellvitge, l'Hospitalet de Llobregat, Spain.
Gutierrez MM; Hospital de Sant Pau, Barcelona, Spain.
Paredes R; Hospital Germans Trias i Pujol, Badalona, Spain; Lluita Contra La Sida Foundation, Badalona, Spain; Universitat de Vic-Universitat Central de Catalunya, Barcelona, Spain; IrsiCaixa AIDS Research Institute, Badalona, Spain.
Clotet B; Hospital Germans Trias i Pujol, Badalona, Spain; Lluita Contra La Sida Foundation, Badalona, Spain; Universitat de Vic-Universitat Central de Catalunya, Barcelona, Spain; IrsiCaixa AIDS Research Institute, Badalona, Spain.
Gatell JM; University of Barcelona, Barcelona, Spain; ViiV Healthcare, Brentford, UK.
Blanco JL; Hospital Clínic-IDIBAPS, Barcelona, Spain; University of Barcelona, Barcelona, Spain.
Martínez E; Hospital Clínic-IDIBAPS, Barcelona, Spain; University of Barcelona, Barcelona, Spain. Electronic address: .; Pokaż więcej
Corporate Authors :: DOLAM study group
Źródło :: The lancet. HIV [Lancet HIV] 2021 Aug; Vol. 8 (8), pp. e463-e473.
Typ publikacji :: Clinical Trial, Phase IV; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Heterocyclic Compounds, 3-Ring/*administration & dosage
Lamivudine/*administration & dosage
Oxazines/*administration & dosage
Piperazines/*administration & dosage
Pyridones/*administration & dosage
Adult ; Anti-HIV Agents/adverse effects ; Cholesterol, HDL/blood ; Drug Therapy, Combination ; Female ; HIV Infections/virology ; Heterocyclic Compounds, 3-Ring/adverse effects ; Humans ; Lamivudine/adverse effects ; Male ; Middle Aged ; Oxazines/adverse effects ; Piperazines/adverse effects ; Pyridones/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Peginterferon Alfa-2a (40KD) Plus Lamivudine or Entecavir in Children With Immune-Tolerant Chronic Hepatitis B.
Autorzy :: Mieli-Vergani G; King's College London Faculty of Life Sciences & Medicine.; Paediatric Liver, Gastrointestinal and Nutrition Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Bansal S; Paediatric Liver, Gastrointestinal and Nutrition Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Daniel JF; Children's Mercy Hospital, Kansas City, KS, United States.
Kansu A; Department of Pediatric Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
Kelly D; Liver Unit, Birmingham Women's & Children's Hospital and University of Birmingham, Birmingham.
Martin C; Roche Products Limited, Welwyn Garden City, United Kingdom.
Tizzard S; Paediatric Liver, Gastrointestinal and Nutrition Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Wirth S; Department of Pediatrics, Helios Medical Center Wuppertal, Witten-Herdecke University, Germany.
Zhou J; RochePharma Product Development Shanghai, Shanghai, China.
Vergani D; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, United Kingdom.; Pokaż więcej
Źródło :: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2021 Aug 01; Vol. 73 (2), pp. 156-160.
Typ publikacji :: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Hepatitis B, Chronic*/drug therapy
Lamivudine*/therapeutic use
Adolescent ; Adult ; Antiviral Agents/adverse effects ; Child ; DNA, Viral/therapeutic use ; Drug Therapy, Combination ; Guanine/analogs & derivatives ; Hepatitis B e Antigens ; Humans ; Interferon-alpha ; Pilot Projects ; Polyethylene Glycols/adverse effects ; Recombinant Proteins/therapeutic use ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Structural basis of HIV inhibition by L-nucleosides: Opportunities for drug development and repurposing.
Autorzy :: Ruiz FX; Center for Advanced Biotechnology and Medicine, and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: .
Hoang A; Center for Advanced Biotechnology and Medicine, and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Dilmore CR; Department of Cell Biology and Molecular Genetics, University of Maryland College Park, College Park, MD 20742, USA.
DeStefano JJ; Department of Cell Biology and Molecular Genetics, University of Maryland College Park, College Park, MD 20742, USA.
Arnold E; Center for Advanced Biotechnology and Medicine, and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: .; Pokaż więcej
Źródło :: Drug discovery today [Drug Discov Today] 2022 Jul; Vol. 27 (7), pp. 1832-1846. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Drug Repositioning*
HIV Infections*/drug therapy
Antiviral Agents/therapeutic use ; Hepatitis B virus ; Humans ; Lamivudine/chemistry ; Lamivudine/pharmacology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance.
Autorzy :: Lai MT; Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Feng M; Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Xu M; Quantitative Biosciences, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Ngo W; Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Diamond TL; Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Hwang C; Global Clinical Development, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Grobler JA; Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Hazuda DJ; Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Asante-Appiah E; Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.; Pokaż więcej
Źródło :: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 May 17; Vol. 66 (5), pp. e0222321. Date of Electronic Publication: 2022 May 02.
Typ publikacji :: Journal Article
MeSH Terms :: Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV-1*/genetics
Deoxyadenosines ; Drug Resistance, Viral/genetics ; Emtricitabine/therapeutic use ; HIV Reverse Transcriptase/genetics ; Humans ; Lamivudine/pharmacology ; Lamivudine/therapeutic use ; Mutation ; Pyridones ; Reverse Transcriptase Inhibitors/pharmacology ; Reverse Transcriptase Inhibitors/therapeutic use ; Triazoles
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
Autorzy :: Fadaka AO; Department of Science and Innovation/Mintek Nanotechnology Innovation Centre, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville, South Africa.
Aruleba RT; Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.
Sibuyi NRS; Department of Science and Innovation/Mintek Nanotechnology Innovation Centre, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville, South Africa.
Klein A; Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville, South Africa.
Madiehe AM; Department of Science and Innovation/Mintek Nanotechnology Innovation Centre, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville, South Africa.; Nanobiotechnology Research Group, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville, South Africa.
Meyer M; Department of Science and Innovation/Mintek Nanotechnology Innovation Centre, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Bellville, South Africa.; Pokaż więcej
Źródło :: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2022 May; Vol. 40 (8), pp. 3416-3427. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/drug therapy
Heterocyclic Compounds*
Coronavirus 3C Proteases ; Hematopoietic Stem Cell Mobilization ; Humans ; Lamivudine ; Ligands ; Lopinavir/pharmacology ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Protease Inhibitors/pharmacology ; SARS-CoV-2
SCR Protocol :: COVID-19 drug treatment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: EVALUATION OF COMBINED RADIATION FOR THE TREATMENT OF LAMIVUDINE AND ZIDOVUDINE VIA AOP.
Autorzy :: ANDRADE DE LUCENA, ALEX LEANDRO
DA ROCHA SANTANA, RAYANY MAGALI
SOARES DE OLIVEIRA, MARCOS ANDRÉ
COSTA ALMEIDA, LUCIANO
MENEZES BEZERRA DUARTE, MARTA MARIA
NAPOLEÃO, DANIELLA CARLA; Pokaż więcej
Alternatywny tytuł :: UTICAJ KOMBINOVANOG ZRAČENJA NA UKLANJANJE LAMIVUDINA I ZIDOVUDINA NAPREDNIM OKSIDACIONIM PROCESIMA.
Źródło :: Chemical Industry & Chemical Engineering Quarterly. Jul-Sep2022, Vol. 28 Issue 3, p179-190. 12p.
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in a multicentre cohort in Spain.
Autorzy :: Suárez-García I; Infectious Diseases Group, Department of Internal Medicine, Hospital Universitario Infanta Sofía (FIIB HUIS HHEN), Madrid, Spain.; Universidad Europea, Madrid, Spain.
Alejos B; National Epidemiology Centre, Instituto de Salud Carlos III, Madrid, Spain.
Ruiz-Algueró M; National Epidemiology Centre, Instituto de Salud Carlos III, Madrid, Spain.
García Yubero C; Department of Hospital Pharmacy, Hospital Universitario Infanta Sofía (FIIB HUIS HHEN), Madrid, Spain.
Moreno C; National Epidemiology Centre, Instituto de Salud Carlos III, Madrid, Spain.
Bernal E; Infectious Diseases Section, Hospital General Universitario Reina Sofía, Murcia, Spain.
Pérez-Is L; FINBA/ISPA, Hospital Universitario Central de Asturias, Avilés, Spain.
Zubero Z; Department of Infectious Diseases. Hospital, Universitario Basurto, Bizkaia, Spain.
de Zárraga Fernández MA; Department of Internal Medicine, Hospital San Agustín, Avilés, Spain.
Samperiz Abad G; Infectious Diseases Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Jarrín I; National Epidemiology Centre, Instituto de Salud Carlos III, Madrid, Spain.; Pokaż więcej
Corporate Authors :: Cohort of the Spanish HIV/AIDS Research Network (CoRIS)
Źródło :: Journal of the International AIDS Society [J Int AIDS Soc] 2021 Jul; Vol. 24 (7), pp. e25758.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Anti-HIV Agents*/administration & dosage
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Lamivudine*/administration & dosage
Lamivudine*/therapeutic use
Dideoxynucleosides/administration & dosage ; Dideoxynucleosides/therapeutic use ; Drug Combinations ; Heterocyclic Compounds, 3-Ring/administration & dosage ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Humans ; Oxazines/administration & dosage ; Oxazines/therapeutic use ; Piperazines/administration & dosage ; Piperazines/therapeutic use ; Pyridones/administration & dosage ; Pyridones/therapeutic use ; Spain ; Tablets/therapeutic use
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 19 19.

Tytuł :: Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States.
Autorzy :: Butler K; Health Economics & Outcomes Research Ltd, Cardiff, United Kingdom.
Anderson SJ; GlaxoSmithKline, Brentford, United Kingdom.
Hayward O; Health Economics & Outcomes Research Ltd, Cardiff, United Kingdom.
Jacob I; Health Economics & Outcomes Research Ltd, Cardiff, United Kingdom.
Punekar YS; ViiV Healthcare, Brentford, United Kingdom.
Evitt LA; ViiV Healthcare, Brentford, United Kingdom.
Oglesby A; ViiV Healthcare, NC.; Pokaż więcej
Źródło :: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2021 Jul; Vol. 27 (7), pp. 891-903.
Typ publikacji :: Journal Article
MeSH Terms :: HIV Infections/*drug therapy
HIV-1/*drug effects
Heterocyclic Compounds, 3-Ring/*economics
Lamivudine/*economics
Oxazines/*economics
Piperazines/*economics
Pyridones/*economics
Cost-Benefit Analysis ; Heterocyclic Compounds, 3-Ring/adverse effects ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Humans ; Lamivudine/adverse effects ; Lamivudine/therapeutic use ; Oxazines/adverse effects ; Oxazines/therapeutic use ; Piperazines/adverse effects ; Piperazines/therapeutic use ; Pyridones/adverse effects ; Pyridones/therapeutic use ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso.
Autorzy :: Mennecier A; Pathogenesis and Control of Chronic and Emerging Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Antilles University, CHU Montpellier, Montpellier, France. Electronic address: .
Kankasa C; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.
Fao P; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Moles JP; Pathogenesis and Control of Chronic and Emerging Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Antilles University, CHU Montpellier, Montpellier, France.
Eymard-Duvernay S; Pathogenesis and Control of Chronic and Emerging Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Antilles University, CHU Montpellier, Montpellier, France.
Mwiya M; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.
Kania D; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Chunda-Liyoka C; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.
Sakana L; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Rutagwera D; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.
Tassembedo S; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Wilfred-Tonga MM; Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.
Mosqueira B; Pathogenesis and Control of Chronic and Emerging Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Antilles University, CHU Montpellier, Montpellier, France.
Tylleskär T; Centre for International Health, University of Bergen, Bergen, Norway.
Nagot N; Pathogenesis and Control of Chronic and Emerging Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Antilles University, CHU Montpellier, Montpellier, France.
Van de Perre P; Pathogenesis and Control of Chronic and Emerging Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Antilles University, CHU Montpellier, Montpellier, France.; Pokaż więcej
Corporate Authors :: ANRS 12397 Study group
Źródło :: Contemporary clinical trials [Contemp Clin Trials] 2021 Jun; Vol. 105, pp. 106402. Date of Electronic Publication: 2021 Apr 17.
Typ publikacji :: Clinical Trial Protocol; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Breast Feeding*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*transmission
Infectious Disease Transmission, Vertical/*prevention & control
Lamivudine/*therapeutic use
Adolescent ; Adult ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Burkina Faso ; COVID-19/epidemiology ; Cross-Sectional Studies ; Female ; HIV Infections/diagnosis ; Humans ; Infant ; Lamivudine/administration & dosage ; Lamivudine/adverse effects ; Pandemics ; Pre-Exposure Prophylaxis/methods ; Research Design ; SARS-CoV-2 ; Viral Load ; Young Adult ; Zambia
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lamivudine"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język